Drug Shortage Report for TEVA-FENTANYL

Last updated on 2025-02-06 History
Report ID 247779
Drug Identification Number 02311925
Brand name TEVA-FENTANYL
Common or Proper name FENTANYL
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) FENTANYL
Strength(s) 12MCG
Dosage form(s) PATCH
Route of administration TRANSDERMAL TRANSDERMAL
Packaging size 5
ATC code N02AB
ATC description OPIOIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2025-02-01
Estimated end date 2025-04-30
Actual end date
Shortage status Actual shortage
Updated date 2025-02-06
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2025-02-06 French Compare
v10 2025-02-06 English Compare
v9 2025-02-03 French Compare
v8 2025-02-03 English Compare
v7 2025-02-02 English Compare
v6 2025-01-30 French Compare
v5 2025-01-30 English Compare
v4 2025-01-23 French Compare
v3 2025-01-23 English Compare
v2 2025-01-15 French Compare
v1 2025-01-15 English Compare

Showing 1 to 11 of 11